ReviewClinical and molecular hepatology2026

Alcohol-aware risk stratification and subtype-specific care pathways across metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and alcohol-associated liver disease, and alcohol-associated liver disease.

Hyo Young Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.